Although the inhibition of AR and signal transduction proteins with bicalutamide plus everolimus is effective, treatment with VN/124-1 in combination with everolimus was superior in maintaining tumour growth suppression in the HP-LNCaP xenograft. The gene discussed is AR; the disease is neoplasm.